In last trading session, Omega Therapeutics Inc (NASDAQ:OMGA) saw 0.39 million shares changing hands with its beta currently measuring 1.99. Company’s recent per share price level of $2.58 trading at -$0.18 or -6.52% at ring of the bell on the day assigns it a market valuation of $142.31M. That closing price of OMGA’s stock is at a discount of -291.09% from its 52-week high price of $10.09 and is indicating a premium of 49.61% from its 52-week low price of $1.30. Taking a look at company’s average trading volume volume of 399.40K if we extend that period to 3-months.
Omega Therapeutics Inc (NASDAQ:OMGA) trade information
Upright in the red during last session for losing -6.52%, in the last five days OMGA remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $2.58 price level, adding 14.0% to its value on the day. Omega Therapeutics Inc’s shares saw a change of -14.29% in year-to-date performance and have moved 13.66% in past 5-day. Omega Therapeutics Inc (NASDAQ:OMGA) showed a performance of -14.57% in past 30-days.
Omega Therapeutics Inc (OMGA) estimates and forecasts
Statistics highlight that Omega Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 91.11% of value to its shares in past 6 months, showing an annual growth rate of 28.33% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 27.00% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.63M for the same. And 5 analysts are in estimates of company making revenue of 1.63M in the next quarter. Company posted 260k and 450k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -48.08% during past 5 years.
OMGA Dividends
Omega Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
